Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD
UK biotech Microbiotica has entered into a multi-year collaboration with Genentech, one of the world’s…
07/06/2018 - 2 minutes
Microbiome: An Emerging Field with Growing Investments
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Show More
Editor's Picks for Microbiome
- UK Startup Surfs Investment Wave in Microbiome with €18M Series A
- Microbiome Medicines Could Power Up CAR-T Cell Therapies
- Investing in the Microbiome in the Age of Covid-19 and Beyond
- The Missing Piece in the Microbiome Field
- No Guts, No Glory: How Microbiome Research is Changing Medicine
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportLatest Microbiome Articles
Do Phages Hold the Key to Modulating the Microbiome?
The human microbiome is emerging as a target for treating a wide range of diseases,…
21/03/2018 - 3 minutes
Could the Microbiome Treat Side Effects of Stem Cell Transplants?
MaaT Pharma, based in Lyon, has received authorization to launch a Phase II trial for…
19/03/2018 - 2 minutes
French Biotech Targets Gut Microbiome to Treat Diabetes
Valbiotis has shown that its treatment restores diversity in a population of gut microorganisms imbalanced…
08/03/2018 - 3 minutes
The First and Only Museum of Microbes Captivates Amsterdam
Micropia, a museum of microbes located in the heart of Amsterdam, uses art to address the big…
24/02/2018 - 2 minutes
Enterome Brings in a €32M Series D for its Microbiome-Based Therapies
Enterome will use the money to progress two of its leading microbiome programs for the…
04/01/2018 - 3 minutes
Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease
BiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets…
20/12/2017 - 2 minutes
Qiagen Joins French Biotech to Build the Next Generation of Microbiome Technology
Biomillenia harnesses the power of bacteria to keep the body healthy. The biotech has joined…
30/11/2017 - 3 minutes
French Microbiome Biotech Gets a €6.5M Leg Up to Market Launch
LNC Therapeutics is ready to take its oral microbiome-based therapeutic to market for obesity. Investors…
28/09/2017 - 2 minutes
French Biotech Gets $20M to Treat the Microbiome with CRISPR Nanobots
Eligo Bioscience has announced its first fundraising round, amassing $20M (€18.5M) that will be put…
26/09/2017 - 3 minutes
EU gives French Biotech €20M to Continue the Fight Against Antibiotic Resistance
Da Volterra has been boosted by a €20M loan to speed up the development of solutions…
22/09/2017 - 3 minutes
Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A
Bayer and Ginkgo Bioworks are launching a new company that will develop new technologies for…
15/09/2017 - 2 minutes
